Dec 18, 2025 | Clinical Outcomes, News
Abstract Introduction Intravenous immune globulin 10% liquid (IVIG 10%) is used in the treatment of primary immunodeficiency (PID). Originally approved in 2012 and then voluntarily withdrawn in 2016, IVIG 10% (BIVIGAM®) underwent manufacturing process improvements by...
Dec 3, 2025 | Clinical Outcomes, News
Abstract Introduction Atherosclerotic cardiovascular disease (ASCVD) is a global health concern. Reducing low-density lipoprotein cholesterol (LDL-C) is critical in ASCVD prevention and treatment. Inclisiran, a novel RNA therapeutic agent, offers a promising solution...
Sep 2, 2025 | Events, News
Atlanta, GA #IDWeek2025 is only a few short weeks away! If you’ve ever considered partnering with Healix to establish or manage an existing infusion center within your practice, IDWeek is a great opportunity to speak one-on-one with our experienced team. Swing by our...
Sep 1, 2025 | Events, News
Chicago, IL #CHEST2025 kicks off on October 19 in Chicago, and we are thrilled to be an exhibitor alongside our colleagues supporting “education for the next era of Chest medicine.” If you’ll be attending, stop by the Healix booth #740 to learn about...
Jun 1, 2025 | Events, News
Miami Beach, FL We’re thrilled to announce that Healix, LLC will be at the 2025 National Infusion Center Association (NICA) Annual Conference on June 20-21 at the Fontainebleau Miami! Join us along with providers, practice managers, advocates, and industry leaders as...
Recent Comments